An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns
NCT ID: NCT01454310
Last Updated: 2011-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
18 participants
INTERVENTIONAL
2010-11-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acellular skin substitute
Wound coverage by acellular skin substitute
Burn wounds are covered by an acellular skin substitute and remains 10-14 days that peals away in line with re-epithelialisation
Autologous skin graft
Autologous skin
Matched burn wound is covered by autologous skin after tangential excision.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wound coverage by acellular skin substitute
Burn wounds are covered by an acellular skin substitute and remains 10-14 days that peals away in line with re-epithelialisation
Autologous skin
Matched burn wound is covered by autologous skin after tangential excision.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* verified deep partial-thickness burns
* early tangential excision of burn wound (3-5 days after trauma)
Exclusion Criteria
* ABSI-Score \>13
* Active tumor or immune-mediated disease
* Patient refusal
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Harald Franz Selig
MD, research assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars P Kamolz, MD, PhD, MSc
Role: STUDY_CHAIR
Medical University of Vienna
Maike Keck, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna, Department of Plastic and Reconstructive Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna, Burn Center, Department of Plastic and Reconstructive Surgery
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Uhlig C, Rapp M, Hartmann B, Hierlemann H, Planck H, Dittel KK. Suprathel-an innovative, resorbable skin substitute for the treatment of burn victims. Burns. 2007 Mar;33(2):221-9. doi: 10.1016/j.burns.2006.04.024. Epub 2006 Nov 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUPRA-VS-STSG-2010
Identifier Type: -
Identifier Source: org_study_id